Xiong Ma Tang (XMT), one of the ancient herbal prescriptions, has been used in treatment of migraine disease. In this study, efficient high-performance liquid chromatographic fingerprints were developed for identification of 11 major marker components, named 1-(β-D-ribofuranosyl)-1H-1,2,4-triazone, gastrodin, ligustrazine, 3,4-bihydroxy benzaldehyde, p-hydroxy benzaldehyde, p-hydroxybenzoic acid, benzoic acid, vanillin, ferulic acid, caffeic acid and senkyunolide I, respectively, in XMT and three related preparations. The analysis of 11 marker compounds was carried out using a Kromasil C 18 reserved-phase column (5 μm, 4.6 × 250 mm) and gradient elution with methanol and aqueous phosphoric acid (0.1%, v/v). The flow rate was 1.0 mL/min and the detector wavelength was set at 276 nm. Mean chromatograms and correlation coefficients of samples were calculated by the software "Similarity Evaluation System for Chromatographic Fingerprint of Traditional Chinese Medicine". The correlation coefficients of XMT and three related preparations ranged from 0.935 to 0.986, 0.909 to 0.949, 0.900 to 0.926 and 0.937 to 0.988, respectively. It was the first time 11 peaks of XMT and three related preparations were identified by comparing with standard compounds. These results have shown that the developed method was efficient for the quality evaluation of XMT and its related preparations.
Introduction
Traditional Chinese Medicines (TCMs) have been practiced for many millennia, and thousands of formulae have been verified based on their undoubted prophylactic and therapeutic effects and gradually accepted in the world. However, their quality control has been an important concern for both health authorities and the public (1, 2) . Among a variety of quality control methods, chromatographic fingerprinting has gained more and more attention recently. It has been widely introduced and accepted by WHO (3), FDA (4), EMEA (5), German Commission E (6), British Herbal Medicine Association (7), Indian Drug Manufacturers' Association (8) , and some other official and non-official organizations as a strategy for the assessment of herbal medicines. Lately, Chinese manufacturers are also required by Chinese State Food and Drug Administration (SFDA) to standardize their botanical injections and the other products using chromatographic fingerprinting (9) .
Chromatographic fingerprint is a chromatogram that represents the chemical characteristics of herbal medicine (5) . Generally, samples with similar chromatographic fingerprints have similar properties. As a result, chromatographic fingerprinting has the potential to determine the identity, authenticity and lot-to-lot consistency of herbal medicines. So far, there have been many chromatographic fingerprint reports of herbal medicines such as Ginkgo biloba (10), Rhizoma chuanxiong (11, 12) , Salvia miltiorrhiza Bunge (13, 14) , Panax notoginseng (15) , Forsythia suspensa (Thunb.) Vahl (16) , Flos Carthami (17), Shenmai injection (18) , BuYang HuanwWu Tang (19) (20) (21) , Liu Wei Di Huang Wan (22) and YuanHu ZhiTong Tablet (23) . Additionally, the origin of the medicinal materials should be given more attention when we research on their chromatographic fingerprint.
Xiong Ma Tang (XMT) is one of the simplest of these ancient formulae, only comprising of Rhizoma Ligustici Chuanxiong (RLC) and Rhizoma Gastrodiae (RG) in a ratio of 4 to 1. This formula was first recorded in Yizong Jinjian by Wu Qian in China in 1742 AD, and has mainly been prescribed since then to people in order to relieve wind syndrome of the head based on its demonstrated ability to invigorate the circulation of "Blood" (body circulation) and "Qi" (vital energy), and eliminate wind and pains. Modern pharmacological research has demonstrated that XMT exhibits outstanding biological activity on migraine. There are some reports about the chemical and pharmacological investigations performed on XMT over the past few decades, which revealed that the water extraction, and the ethyl acetate part (EAP) and n-butyl alcohol part (NBP) of XMT showed a significant effect of decreasing nitric oxide, calcitonin gene-related peptide, 5-hydroxytryptamine and the endothelin level (24) . Due to its better bioactivities, as well as the increasing interest in the application and modernization of TCM products, the quality control of XMT, in relation to its many bioactive components, has become one of the most important and key issues.
Until now, there were few reports on the fingerprints of XMT and its related traditional Chinese medicinal preparations (TCMPs). So, we aimed to establish high-performance liquid chromatographic (HPLC) fingerprints to investigate the quality of XMT and its related TCMPs. The mean chromatograms and correlation coefficients of XMT and its related TCMPs were obtained by using the software "Similarity Evaluation System for Chromatographic Fingerprint of TCM". Then the relative retention time (RRT) and relative peak area (RPA) of "common peaks" were calculated. At last, the corresponding quality was evaluated and 11 compounds in the fingerprint chromatogram were identified by HPLC-UV with reference standards for the first time.
Experimental
Reagents and chemicals HPLC-grade methanol (Merck, Germany) was used for the HPLC analysis. Analytical reagent-grade methanol, petroleum ether (boiling range, 60-90°C), ethyl acetate and n-Butanol were used for the extraction and isolation. Standards of ligustrazine were purchased from the National Institute for Control of Biological and Pharmaceutical Products of China. Standards of 1-(β-Dribofuranosyl)-1H-1,2,4-triazone, gastrodin, 3,4-bihydroxy benzaldehyde, p-hydroxy benzaldehyde, p-hydroxybenzoic acid, benzoic acid, vanillin, ferulic acid, caffeic acid and senkyunolide I were isolated by repeated silica gel, Sephadex LH-20 and Rp-18 silica gel column chromatography in our laboratory for the first time (25) . Their identities were elucidated or confirmed by comparison of their spectral data (UV, IR, MS, 1 H-NMR and 13 C-NMR) with individual purities of no <98.0%. Their structures are shown in Figure 1 and the chromatograms of crude drug and standard compounds are shown in Figure 2 . Plant materials and commercial products RLC and RG were purchased from the Jiu-zhi-tang drug store chain (Changsha, China) for preparing XMT and their extractions. From 12 batches of commercial products, Tian-shu Capsules (TSCs), which are also constituted of RLC and RG, were purchased from local drug stores in China. All voucher specimens were identified by Prof. Xiangqian Liu, one of the authors in this manuscript, and were deposited at the Key Laboratory of Modernization of Chinese Medicine in Hunan University of Chinese Medicine, Changsha, China.
Instrumentation and chromatographic conditions
HPLC was carried out using an Agilent 1200 series HPLC system equipped with a quaternary pump with an on-line degasser, autosampler, column oven and UV detector. The separation was achieved on a Kromasil C 18 column (5 μm, 4.6 × 250 mm) and the column temperature was maintained at 30°C. The mobile phase consisted of (A) aqueous phosphoric acid (0.1%, v/v) and (B) methanol, and the gradient elution scheme involved the use of 5% B at 0-5 min, 5-28% B at 5-18 min, 28% B at 18-27 min, 28-95% B at 27-60 min, 95% B at 60-65 min, and then the system was retuned to initial conditions after 10 min of re-equilibration time. The fingerprint chromatograms were recorded at an optimized wavelength of 276 nm. The flow rate was 1.0 mL/min and the injection volume of each sample was 20 μL.
The software "Similarity Evaluation System for Chromatographic Fingerprint of TCM", published by Chinese Pharmacopoeia Commission (ChPC, version 2004A), was employed to generate the mean chromatogram, calculate the correlation coefficients and carry out the similarity analysis of the samples with the mean chromatogram on an Intel Core TM i3 M350 personal computer.
Methods

Preparation of sample solution
Preparation of XMT, RLC and RG sample solution The crushed herbs of RLC (40 g) and RG (10 g) were immersed in eight times their volume of water, decocted at 100°C for 60 min and later filtered. The residue was added to six times their volume of water, decocted 30 min again and filtered. The combined filtrate was subsequently concentrated to 50 mL at 40°C under reduced pressure. After centrifugation for 10 min at 3,000 rpm, 20 mL of the supernatant, which was filtered through a 0.45 μm nylon filter (Agilent Technologies, Germany), was pipetted into a 25 mL volumetric flask and scaled to capacity with water at room temperature and stored at 4°C. According to the preparation method of XMT samples, 0.8 g RLC/ml and 0.8 g RG/ml sample solution were prepared and stored at 4°C.
Preparation of EAP and NBP sample solution
The prepared XMT decoction was partitioned successively with petroleum ether, ethyl acetate and n-Butanol. Then, the solvent was recovered and evaporated to dryness, and the residue was dissolved in 50 mL of water. After centrifugation, filtering, pipetting and scaling to capacity, EAP and NBP samples were prepared and stored at 4°C as the test solution.
Preparation of TSC sample solution
To a flask, 1 g of the fine powder was added. Then, 25 mL of 50% methanol was added. After 30 min of ultrasonic treatment ( power 250 W, frequency 40 kHz), it is shaken well and filtered. The filtrate is taken as the test solution.
Preparation of standard solution
The stock solutions of 1-(β-D-ribofuranosyl)-1H-1,2,4-triazone (1), ligustrazine (5), 3,4-bihydroxy benzaldehyde (6), p-hydroxy benzaldehyde (7), p-hydroxybenzoic acid (8), benzoic acid (9), vanillin (10), ferulic acid (12) , caffeic acid (14) and senkyunolide I (15) were prepared separately in methanol at a concentration of 0.4 mg/mL and gastrodin (2) was prepared at a concentration of 1.0 mg/mL. They were stored at 4°C before use.
Results
Data analysis and quality evaluation
The software "Similarity Evaluation System for Chromatographic Fingerprint of TCM", published by ChPC (Version 2004A), was mainly applied in the similarity analysis of chromatographic and spectral patterns. In this study, the software was employed to synchronize comparison among different samples, as well as to compute and generate the mean chromatogram as a representative standard fingerprint chromatogram for a group of chromatograms, as shown in Figures 3  and 4 . Then the correlation coefficients of samples with the mean chromatogram could be provided by this software (26) and the results are presented in Table I .
After the analysis, recognition and comparison of chromatographic samples can provide characteristic information. One preferred index of composition is chosen as the reference standard, which is structurally clear, stable and easy to obtain. The RRT is the ratio of each chromatographic peak retention time to the reference peak retention time, which is calculated by the following formula: where A i represents each chromatographic peak area and A s is the peak area of the reference peak. If there are no peaks for a certain fingerprint graph in a certain relative retention time and the relative peak area is zero, the relative series number is still given to guarantee that every chromatographic fingerprint has been obtained using the same number of chromatographic peaks. There were 11 "common peaks" ( peak nos. 1, 2, 5, 6, 7, 8, 9, 10, 12, 14 and 15) existing in XMT and the mean chromatograms are shown in Figure 4 . The RRT and RPA of each common peak were calculated, which could semi-quantitatively express the chemical properties in the chromatographic profile of samples. The results are presented in Tables II, respectively .
Methodology validation
HPLC fingerprint determination is usually different from a general analytical method. The authentication and identification of a drug and its products can be accurately performed using the chromatographic fingerprints, even if batches or concentrations varied among samples (27) . Considering these characteristics of fingerprints, the RRT and RPA of 11 "common peaks" were used to evaluate the quality of the samples and the results are presented in Table II . 
Precision
The precision was determined by replicate injections of the same sample of XMT six times in 1 day. The relative standard deviations (RSDs) of RRT and RPA were lower than 1.25 and 2.60%, respectively (Tables III).
Repeatability
The repeatability was assessed by analyzing six independently prepared samples of XMT, EAP, NBP and TSC. The RSDs of RRT and RPA were lower than 1.21 and 2.16%, respectively. 
Sample stability test
The sample stability test was determined with one sample of XMT, EAP, NBP and TSC during 3 days. The solution was injected at 0, 12, 24, 36, 48 and 72 h, respectively. The RSDs of RRT and RPA were lower than 1.24 and 2.12%, respectively. The results indicated that the sample remained stable for 3 days. All results of injection precision, repeatability and stability test indicate that this method was adequate, valid and applicable. 
Discussion
According to the literature (28), methanol-water mobile phases were recommended to separate the constituents of XMT. When the pH was adjusted to 2.5, the ionization of phosphoric acid could be restrained to get better peak shapes. Three columns were screened with methanol/0.1% aqueous phosphoric acid (B/A) as the mobile phase. The Kromasil C 18 column was found to be better than BDS-Hypersil C 18 or AT.LICHROM ODS-C 18 . A mobile phase including phosphate was also examined. However, no improvement in resolution was observed. Additionally, it was beneficial for the robustness of the method if a relatively simple mobile phase was used. Thus, it was decided to use the chromatographic system consisting of the Kromasil C 18 reserved-phase column and a methanol/0.1% phosphoric acid mobile phase combination, to proceed to the next optimization step.
After the suitable stationary and mobile phases were decided, other factors of the chromatogram were investigated including column temperature, wavelength and injection volume. Column temperature is recognized as an important parameter influencing retention, selectivity, pressure and column stability. In this experiment, 25°C, 30°C and 35°C were screened and the results indicated that 30°C was the best. The maximum absorbance of each marker compound shows differences, ranging from 322 to 220 nm. Taking all classes of compounds into consideration, 276 nm was selected as the detection wavelength. Since phosphoric acid could reduce ionization and keep the baseline stable, three concentrations of phosphoric acid (0.2, 0.1 and 0.05%) were investigated. Although two concentrations of phosphoric acid (0.2 and 0.1%) could reduce the ionization, the latter was selected for ensuring the robustness of the fixed phase. Additionally, the injection volume was also investigated, and 20 μL was found to be the most suitable volume.
As a result, detection wavelength, column temperature, acid concentration and injection volume were set at 276 nm, 30°C, 0.1% and 20 μL, respectively.
Chromatographic fingerprints were obtained from 12 batches of XMT, EAP, BNP and TSC, respectively. The means of all chromatograms are given in Figure 4 and the similarity values of all imported chromatograms with respect to the reference fingerprint are tabulated in Table I . There were 17 common peaks in all 12 batches of XMT and the sum of their areas accounted for more than 90% of the overall peak area. Peaks 1, 2, 5, 6, 7, 8, 9, 10, 12, 14 and 15 were identified as 1-(β-D-ribofuranosyl)-1H-1,2,4-triazone, gastrodin, ligustrazine, 3,4-bihydroxy benzaldehyde, p-hydroxy benzaldehyde, p-hydroxybenzoic acid, benzoic acid, vanillin, ferulic acid, caffeic acid and senkyunolide I, respectively, by comparing with the corresponding chemical references under the same condition (Figure 2 ). The RSDs of RRT and RPA of the other common peaks with respect to peak 9 from all samples were <3%, which indicated that the chemical constituents of XMT, EPA, BNP and TSC from different batches were generally consistent with distinct relative peak intensities.
Conclusion
A HPLC-UV method for fingerprint analysis of XMT and three related preparations was developed. The mean chromatograms and correlation coefficients were obtained with standardized procedure. Eleven bioactive constituents in XMT and its related commercial products were identified by comparing with reference standards in the first time. It was also found that 1-(β-D-ribofuranosyl)-1H-1, 2, 4-triazone, gastrodin, p-hydroxybenzoic acid and benzoic acid mainly come from RG, and ligustrazine, 3,4-bihydroxy benzaldehyde, p-hydroxy benzaldehyde, vanillin, ferulic acid, caffeic acid and senkyunolide I come from RLC in XMT.
In addition, by comparing the common peak chromatograms with the crude drug and standard compounds, it is found that the therapeutic substances of EAP mainly come from RLC, and the therapeutic substances of NBP mainly come from RG. And it can be further speculated that ligustrazine, which exists in neither EAP nor NBP, may not be the therapeutic substance in XMT treated for migraine.
Through comparing the fingerprint of XMT with that of TSC, some constituents were not detected in TSC, probably due to the different drug proportions or the different methods of preparation. The method for fingerprint analysis of XMT and three related preparations is superior to the pharmacopoeia method in the aspects of peak curve, resolution and system selectivity.
The results demonstrated that this developed method was feasible for comprehensive quality evaluation of XMT and its related TCMPs.
